Adverts

Open Access Articles- Top Results for U-89843A

U-89843A

</th></tr>
U-89843A
200px
Systematic (IUPAC) name
6,7-dimethyl-2,4-dipyrrolidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine
Clinical data
  • Legal
Identifiers
157013-32-6 7pxY
PubChem CID 154689
Chemical data
Formula C16H23N5
285.387 g/mol
 14pxY (what is this?)  (verify)

U-89843A (PNU-89843) is a sedative drug which acts as an agonist at GABAA receptors, specifically acting as a positive allosteric modulator selective for the α1, α3 and α6 subtypes.[1] It has sedative effects in animals but without causing ataxia, and also acts as an antioxidant and may have neuroprotective effects.[2] It was developed by a team at Upjohn in the 1990s.[3]

References

  1. Im, HK; Im, WB; Pregenzer, JF; Carter, DB; Hamilton, BJ (1995). "U-89843A is a novel allosteric modulator of gamma-aminobutyric acidA receptors". The Journal of Pharmacology and Experimental Therapeutics 275 (3): 1390–5. PMID 8531107. 
  2. Bundy, GL; Ayer, DE; Banitt, LS; Belonga, KL; Mizsak, SA; Palmer, JR; Tustin, JM; Chin, JE et al. (1995). "Synthesis of novel 2,4-diaminopyrrolo-2,3-dpyrimidines with antioxidant, neuroprotective, and antiasthma activity". Journal of Medical Chemistry 38 (21): 4161–3. PMID 7473542. doi:10.1021/jm00021a004. 
  3. US Patent 5502187 Pharmaceutically active bicyclic-heterocyclic amines


Lua error in package.lua at line 80: module 'Module:Buffer' not found.